NITE - Nightstar Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/20169/30/2016
Total Revenue----
Cost of Revenue---471.332
Gross Profit----471.332
Operating Expenses
Research Development31,58520,50210,1656,184.431
Selling General and Administrative12,5727,0012,0553,645.808
Non Recurring----
Others----
Total Operating Expenses44,15727,50312,22010,395.817
Operating Income or Loss-44,157-27,503-12,220-10,395.817
Income from Continuing Operations
Total Other Income/Expenses Net6,855-2,14622-13.108
Earnings Before Interest and Taxes-44,157-27,503-12,220-10,395.817
Interest Expense----0.089
Income Before Tax-37,302-29,649-12,198-10,408.925
Income Tax Expense-44037--1,704.089
Minority Interest----
Net Income From Continuing Ops-36,862-29,686-12,198-8,704.836
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-36,862-29,686-12,198-8,704.836
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-36,862-29,686-12,198-8,704.836